病院・介護施設向けプロバイオティクスの世界市場レポート 2025年

病院・介護施設向けプロバイオティクスの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.44％で26億1,000万米ドルに成長します。今後、プロバイオティクスの利用拡大、消化器系の健康ソリューションに対する需要の高まり、プロバイオティクスに対する認知度の向上、院内感染（HAI）予防への重点化、プロバイオティクスをベースとした医療栄養への投資の拡大などが予測期間の成長を牽引するとみられます。予測期間における主な動向としては、プロバイオティクス製剤の革新、特定のヘルスケア環境に合わせた送達方法の強化、感染予防を目的とした新しいプロバイオティクス、高齢者や免疫不全患者向けの特殊なプロバイオティクスの開発、デジタル技術の統合などが挙げられます。

胃腸疾患の有病率の増加は、病院・介護施設向けプロバイオティクス市場の拡大を牽引すると予想されます。これらの疾患には、過敏性腸症候群（IBS）、炎症性腸疾患（IBD）、胃食道逆流症（GERD）、便秘など、消化器系に影響を及ぼすさまざまな疾患が含まれます。これらの疾患の増加は、不健康な食習慣、加工食品の摂取量の増加、座りっぱなしのライフスタイル、ストレスレベルの上昇などの要因と関連しています。病院や介護施設で使用されるプロバイオティクスは、腸内の善玉菌のバランスを回復させ、消化器系の健康を改善し、下痢、便秘、腹部膨満感などの症状を緩和することで、胃腸障害の管理に役立ちます。例えば、2023年12月、英国の非営利団体であるIBDレジストリは、炎症性腸疾患（IBD）の患者数が2023年までに5,300人を突破し、2022年と比較して3,000人以上増加すると報告しました。その結果、消化器疾患の罹患率の上昇が病院・介護施設向けプロバイオティクス市場の成長に寄与しています。

病院・介護施設向けプロバイオティクス市場で事業を展開する企業は、腸の健康を増進し、回復を促進し、抗生物質に伴う副作用を最小限に抑えるプロバイオティクス・ソリューションなどの革新的な製品の創出に注力しています。プロバイオティクス・ソリューションには生きた微生物が含まれており、十分な量を摂取することで消化器官内の善玉菌のバランスを改善し、健康上のメリットをもたらします。例えば、2024年10月、スウェーデンのバイオテクノロジー企業であるProbi AB社は、ヘルスケア環境向けに「Metabolic Health by Probi」を発売しました。この臨床的に裏付けされたプロバイオティック・ソリューションは、2つの独自菌株、ラクチプランタラム299v（LP299V）とラクティクセイバシラス・パラカゼイ8700：2（L. Paracasei 8700：2）を組み合わせ、代謝の健康、心臓血管の健康、体重管理、血圧調整を促進します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界病院・介護施設向けプロバイオティクス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の病院・介護施設向けプロバイオティクス市場：成長率分析
• 世界の病院・介護施設向けプロバイオティクス市場の実績：規模と成長, 2019-2024
• 世界の病院・介護施設向けプロバイオティクス市場の予測：規模と成長, 2024-2029, 2034F
• 世界病院・介護施設向けプロバイオティクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の病院・介護施設向けプロバイオティクス市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質関連下痢
• 過敏性腸症候群
• クロストリジウム・ディフィシル感染症
• 炎症性腸疾患
• 一般的な腸の健康
• 世界の病院・介護施設向けプロバイオティクス市場処方タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カプセル
• 粉
• 液体
• ソフトチュー
• プロバイオティクスヨーグルト
• 世界の病院・介護施設向けプロバイオティクス市場患者グループ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乳児
• 大人
• お年寄り
• 免疫不全患者
• 胃腸疾患の患者
• 世界の病院・介護施設向けプロバイオティクス市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 介護施設
• 薬局
• オンライン小売
• ヘルスケア施設
• 世界の病院・介護施設向けプロバイオティクス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腸の健康
• 免疫
• ウェルネス
• その他の用途
• 世界の病院・介護施設向けプロバイオティクス市場抗生物質関連下痢症（AAD）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• AADの予防
• AADの治療
• 世界の病院・介護施設向けプロバイオティクス市場過敏性腸症候群（IBS）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 下痢を伴う過敏性腸症候群（IBS-D）
• 便秘を伴う過敏性腸症候群（IBS-C）
• 混合性IBS（IBS-M）
• 世界の病院・介護施設向けプロバイオティクス市場クロストリジウム・ディフィシル感染症（CDI）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• CDI再発の予防
• CDIの治療
• 世界の病院・介護施設向けプロバイオティクス市場炎症性腸疾患（IBD）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• クローン病
• 潰瘍性大腸炎
• 世界の病院・介護施設向けプロバイオティクス市場、タイプ別の腸の健康に関するサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫システムのサポート
• 消化器系の健康
• 腸内微生物叢の回復

第7章 地域別・国別分析

• 世界の病院・介護施設向けプロバイオティクス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の病院・介護施設向けプロバイオティクス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 病院・介護施設向けプロバイオティクス市場：競合情勢
• 病院・介護施設向けプロバイオティクス市場：企業プロファイル
  • Nestle Health Science Overview, Products and Services, Strategy and Financial Analysis
  • BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Lactalis Group Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Danone S.A.
• General Mills Inc.
• Arla Foods Group
• DuPont de Nemours Inc.
• Kerry Group plc
• Koninklijke DSM N.V.
• Glanbia PLC
• Yakult Honsha Co. Ltd.
• Chr. Hansen Holding A/S
• Lallemand Inc.
• BioGaia AB
• Klaire Labs
• SymbioPharm GmbH
• Synlogic Inc.
• Vitakem Nutraceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 病院・介護施設向けプロバイオティクス市場2029：新たな機会を提供する国
• 病院・介護施設向けプロバイオティクス市場2029：新たな機会を提供するセグメント
• 病院・介護施設向けプロバイオティクス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hospital and nursing home probiotics are dietary supplements containing live microorganisms, typically beneficial bacteria, that provide health benefits when consumed in adequate amounts. These probiotics are particularly valuable for supporting digestive health, boosting immune function, and improving general wellbeing, especially for vulnerable populations such as the elderly and patients with weakened immune systems.

The primary indications for using probiotics in hospital and nursing home settings include conditions such as antibiotic-associated diarrhea, irritable bowel syndrome (IBS), Clostridium difficile infection, inflammatory bowel disease (IBD), and general gut health maintenance. Antibiotic-associated diarrhea, in particular, is a common issue resulting from the disruption of gut microbiota due to antibiotics, and probiotics are often used to restore balance and alleviate symptoms. Probiotics come in various formulations, including capsules, powders, liquids, soft chews, and probiotic yogurt, allowing for flexible administration tailored to the needs of different patient groups, such as infants, adults, the elderly, immunocompromised patients, and those with gastrointestinal disorders. These products are distributed through a variety of channels, including hospitals, nursing homes, pharmacies, online retail, and healthcare facilities, and they are used primarily in areas related to gut health, immunity, and overall wellness.

The hospital and nursing home probiotics market research report is one of a series of new reports from The Business Research Company that provides hospital and nursing home probiotics market statistics, including the hospital and nursing home probiotics industry global market size, regional shares, competitors with the hospital and nursing home probiotics market share, detailed hospital and nursing home probiotics market segments, market trends, and opportunities, and any further data you may need to thrive in the hospital and nursing home probiotics industry. This hospital and nursing home probiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hospital and nursing home probiotics market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.69 billion in 2025 at a compound annual growth rate (CAGR) of 11.81%. The growth observed in the historical period can be credited to the increasing awareness surrounding gut health, a higher prevalence of gastrointestinal disorders, the rising use of probiotics in healthcare, and the growing body of evidence highlighting the health benefits of probiotics.

The hospital and nursing home probiotics market size is expected to see rapid growth in the next few years. It will grow to $2.61 billion in 2029 at a compound annual growth rate (CAGR) of 11.44%. Looking ahead, the growth in the forecast period is expected to be driven by the expanding use of probiotics, a higher demand for digestive health solutions, increased awareness of probiotics, a stronger emphasis on preventing hospital-acquired infections (HAIs), and growing investments in probiotic-based medical nutrition. Key trends in the forecast period include innovations in probiotic formulations, enhancements in delivery methods tailored for specific healthcare environments, new probiotics aimed at infection prevention, the development of specialized probiotics for the elderly and immunocompromised patients, and the integration of digital technologies.

The growing prevalence of gastrointestinal disorders is expected to drive the expansion of the hospital and nursing home probiotics market. These disorders encompass various conditions affecting the digestive system, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and constipation. The rise in these conditions is linked to factors such as unhealthy eating habits, a higher intake of processed foods, sedentary lifestyles, and elevated stress levels. Probiotics used in hospitals and nursing homes help manage gastrointestinal disorders by restoring the balance of beneficial bacteria in the gut, improving digestive health, and alleviating symptoms such as diarrhea, constipation, and bloating. For example, in December 2023, the IBD Registry, a UK-based non-profit organization, reported that the number of people with inflammatory bowel disease (IBD) surpassed 5,300 by 2023, an increase of more than 3,000 individuals compared to 2022. As a result, the rising incidence of gastrointestinal disorders is contributing to the growth of the hospital and nursing home probiotics market.

Companies operating in the hospital and nursing home probiotics market are focusing on creating innovative products such as probiotic solutions to enhance gut health, accelerate recovery, and minimize side effects associated with antibiotics. Probiotic solutions contain live microorganisms that offer health benefits when consumed in sufficient quantities, typically by improving the balance of good bacteria in the digestive system. For example, in October 2024, Probi AB, a biotechnology company from Sweden, launched "Metabolic Health by Probi" for healthcare environments. This clinically supported probiotic solution combines two proprietary strains, Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2), to promote metabolic health, cardiovascular well-being, weight management, and blood pressure regulation.

In June 2023, Clasado Limited, a UK-based biotechnology firm, collaborated with Probi AB to further develop synbiotic products targeting gut health. The partnership aims to combine their expertise to advance the development and commercialization of scientifically supported synbiotics, which offer specific health benefits for consumers. Probi AB, based in Sweden, specializes in the development and commercialization of probiotic products backed by scientific research, preclinical studies, and clinical trials.

Major players in the hospital and nursing home probiotics market are Nestle Health Science, BASF SE, Procter & Gamble Company, Abbott Laboratories, Lactalis Group, Danone S.A., General Mills Inc., Arla Foods, DuPont de Nemours Inc., Kerry Group plc, Koninklijke DSM N.V., Glanbia PLC, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., BioGaia AB, Klaire Labs, SymbioPharm GmbH, Synlogic Inc., Vitakem Nutraceuticals.

North America was the largest region in the hospital and nursing home probiotics market in 2024. The regions covered in hospital and nursing home probiotics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hospital and nursing home probiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hospital and nursing home probiotics market includes revenues earned by entities by sales of probiotic-infused wound care products, probiotic-infused foods, and medical-grade probiotics and related services such as probiotic therapy and consultation, infection control and prevention, probiotic supplementation programs, and probiotic administration monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hospital And Nursing Home Probiotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hospital and nursing home probiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hospital and nursing home probiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hospital and nursing home probiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Indication: Antibiotic-Associated Diarrhea; Irritable Bowel Syndrome; Clostridium difficile Infection; Inflammatory Bowel Disease; General Gut Health
• 2) By Formulation Type: Capsules; Powder; Liquid; Soft Chew; Probiotic Yogurt
• 3) By Patient Group: Infants; Adults; Elderly; Immunocompromised Patients; Patients With Gastrointestinal Disorders
• 4) By Distribution Channel: Hospitals; Nursing Homes; Pharmacies; Online Retail; Healthcare Facilities
• 5) By Application: Gut Health; Immunity; Wellness; Other Applications
• Subsegments:
• 1) By Antibiotic-Associated Diarrhea (AAD): Prevention of AAD; Treatment of AAD
• 2) By Irritable Bowel Syndrome (IBS): IBS With Diarrhea (IBS-D); IBS With Constipation (IBS-C); Mixed IBS (IBS-M)
• 3) By Clostridium Difficile Infection (CDI): Prevention of CDI Recurrence; Treatment Of CDI
• 4) By Inflammatory Bowel Disease (IBD): Crohn's Disease; Ulcerative Colitis
• 5) By General Gut Health: Immune System Support; Digestive Health; Gut Microbiome Restoration
• Companies Mentioned: Nestle Health Science; BASF SE; Procter & Gamble Company; Abbott Laboratories; Lactalis Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hospital And Nursing Home Probiotics Market Characteristics

3. Hospital And Nursing Home Probiotics Market Trends And Strategies

4. Hospital And Nursing Home Probiotics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hospital And Nursing Home Probiotics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hospital And Nursing Home Probiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hospital And Nursing Home Probiotics Market Growth Rate Analysis
• 5.4. Global Hospital And Nursing Home Probiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hospital And Nursing Home Probiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hospital And Nursing Home Probiotics Total Addressable Market (TAM)

6. Hospital And Nursing Home Probiotics Market Segmentation

• 6.1. Global Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotic-Associated Diarrhea
• Irritable Bowel Syndrome
• Clostridium difficile Infection
• Inflammatory Bowel Disease
• General Gut Health
• 6.2. Global Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsules
• Powder
• Liquid
• Soft Chew
• Probiotic Yogurt
• 6.3. Global Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infants
• Adults
• Elderly
• Immunocompromised Patients
• Patients With Gastrointestinal Disorders
• 6.4. Global Hospital And Nursing Home Probiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Nursing Homes
• Pharmacies
• Online Retail
• Healthcare Facilities
• 6.5. Global Hospital And Nursing Home Probiotics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gut Health
• Immunity
• Wellness
• Other Applications
• 6.6. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Antibiotic-Associated Diarrhea (AAD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prevention of AAD
• Treatment of AAD
• 6.7. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Irritable Bowel Syndrome (IBS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• IBS With Diarrhea (IBS-D)
• IBS With Constipation (IBS-C)
• Mixed IBS (IBS-M)
• 6.8. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Clostridium Difficile Infection (CDI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prevention of CDI Recurrence
• Treatment Of CDI
• 6.9. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Inflammatory Bowel Disease (IBD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Crohn's Disease
• Ulcerative Colitis
• 6.10. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of General Gut Health, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immune System Support
• Digestive Health
• Gut Microbiome Restoration

7. Hospital And Nursing Home Probiotics Market Regional And Country Analysis

• 7.1. Global Hospital And Nursing Home Probiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hospital And Nursing Home Probiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hospital And Nursing Home Probiotics Market

• 8.1. Asia-Pacific Hospital And Nursing Home Probiotics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hospital And Nursing Home Probiotics Market

• 9.1. China Hospital And Nursing Home Probiotics Market Overview
• 9.2. China Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hospital And Nursing Home Probiotics Market

• 10.1. India Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hospital And Nursing Home Probiotics Market

• 11.1. Japan Hospital And Nursing Home Probiotics Market Overview
• 11.2. Japan Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hospital And Nursing Home Probiotics Market

• 12.1. Australia Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hospital And Nursing Home Probiotics Market

• 13.1. Indonesia Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hospital And Nursing Home Probiotics Market

• 14.1. South Korea Hospital And Nursing Home Probiotics Market Overview
• 14.2. South Korea Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hospital And Nursing Home Probiotics Market

• 15.1. Western Europe Hospital And Nursing Home Probiotics Market Overview
• 15.2. Western Europe Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hospital And Nursing Home Probiotics Market

• 16.1. UK Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hospital And Nursing Home Probiotics Market

• 17.1. Germany Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hospital And Nursing Home Probiotics Market

• 18.1. France Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hospital And Nursing Home Probiotics Market

• 19.1. Italy Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hospital And Nursing Home Probiotics Market

• 20.1. Spain Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hospital And Nursing Home Probiotics Market

• 21.1. Eastern Europe Hospital And Nursing Home Probiotics Market Overview
• 21.2. Eastern Europe Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hospital And Nursing Home Probiotics Market

• 22.1. Russia Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hospital And Nursing Home Probiotics Market

• 23.1. North America Hospital And Nursing Home Probiotics Market Overview
• 23.2. North America Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hospital And Nursing Home Probiotics Market

• 24.1. USA Hospital And Nursing Home Probiotics Market Overview
• 24.2. USA Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hospital And Nursing Home Probiotics Market

• 25.1. Canada Hospital And Nursing Home Probiotics Market Overview
• 25.2. Canada Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hospital And Nursing Home Probiotics Market

• 26.1. South America Hospital And Nursing Home Probiotics Market Overview
• 26.2. South America Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hospital And Nursing Home Probiotics Market

• 27.1. Brazil Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hospital And Nursing Home Probiotics Market

• 28.1. Middle East Hospital And Nursing Home Probiotics Market Overview
• 28.2. Middle East Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hospital And Nursing Home Probiotics Market

• 29.1. Africa Hospital And Nursing Home Probiotics Market Overview
• 29.2. Africa Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hospital And Nursing Home Probiotics Market Competitive Landscape And Company Profiles

• 30.1. Hospital And Nursing Home Probiotics Market Competitive Landscape
• 30.2. Hospital And Nursing Home Probiotics Market Company Profiles
  • 30.2.1. Nestle Health Science Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lactalis Group Overview, Products and Services, Strategy and Financial Analysis

31. Hospital And Nursing Home Probiotics Market Other Major And Innovative Companies

• 31.1. Danone S.A.
• 31.2. General Mills Inc.
• 31.3. Arla Foods Group
• 31.4. DuPont de Nemours Inc.
• 31.5. Kerry Group plc
• 31.6. Koninklijke DSM N.V.
• 31.7. Glanbia PLC
• 31.8. Yakult Honsha Co. Ltd.
• 31.9. Chr. Hansen Holding A/S
• 31.10. Lallemand Inc.
• 31.11. BioGaia AB
• 31.12. Klaire Labs
• 31.13. SymbioPharm GmbH
• 31.14. Synlogic Inc.
• 31.15. Vitakem Nutraceuticals

32. Global Hospital And Nursing Home Probiotics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hospital And Nursing Home Probiotics Market

34. Recent Developments In The Hospital And Nursing Home Probiotics Market

35. Hospital And Nursing Home Probiotics Market High Potential Countries, Segments and Strategies

• 35.1 Hospital And Nursing Home Probiotics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hospital And Nursing Home Probiotics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hospital And Nursing Home Probiotics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer